Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

Cara Therapeutics Study Site, New York

Cara Therapeutics Study Site, New York

Cara Therapeutics Study Site, Horseheads

Cara Therapeutics Study Site, Richmond

Cara Therapeutics Study Site, Columbus

Cara Therapeutics Study Site, Miami Lakes

Cara Therapeutics Study Site 2, Miami

Cara Therapeutics Study Site, Sweetwater

Cara Therapeutics Study Site, Miami

Cara Therapeutics Study Site, Aventura

Cara Therapeutics Study Site, Sarasota

Cara Therapeutics Study Site, Ocala

Cara Therapeutics Study Site, Birmingham

Cara Therapeutics Study Site, Anniston

Cara Therapeutics Study Site, Cleveland

Cara Therapeutics Study Site, Rapid City

Cara Therapeutics Study Site, Metairie

Cara Therapeutics Study Site, New Orleans

Cara Therapeutics Study Site, Baton Rouge

Cara Therapeutics Study Site, Bryant

Cara Therapeutics Study Site, Oklahoma City

Cara Therapeutics Study Site, Tulsa

Cara Therapeutics Study Site, Dallas

Cara Therapeutics Study Site, Cypress

Cara Therapeutics Study Site 2, Austin

Cara Therapeutics Study Site, Austin

Cara Therapeutics Study Site, Boise

Cara Therapeutics Study Site 2, Boise

Cara Therapeutics Study Site, Salt Lake City

Cara Therapeutics Study Site, Scottsdale

Cara Therapeutics Study Site 2, Las Vegas

Cara Therapeutics Study Site, Lomita

Cara Therapeutics Study Site, Fountain Valley

Cara Therapeutics Study Site, Medford

Cara Therapeutics Study Site, Cromwell

Cara Therapeutics Study Site, Farmington

Cara Therapeutics Study Site, Brighton

Cara Therapeutics Study Site, Berlin

Cara Therapeutics Study Site, London

Cara Therapeutics Study Site, Montreal